Dividend stocks remain appealing even to wealthy investors who don't rely on income. AbbVie, Johnson & Johnson, and Pfizer ...

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of ...

It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

Many billionaires who definitely don't need income still have dividend stocks in their portfolios. Which dividend stocks ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Stocks knocked down in the first ten months of the year often suffer further damage as people sell for tax losses. But they ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?

The appetite for high-risk investments really increased following Donald Trump’s presidential victory. Indeed, gold — a ...

Last year, the S&P 500 reached new highs despite geopolitical tensions and market pressures. Defensive stocks in sectors like ...